EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metabolite

Banhi Biswas, Junlin Zhuo iD, Jürgen Bosch iD, Hien Vu, Lorencia Pak, Rameez Raja, Anuradha Roy, Alessandro Panattoni iD, Michal Maryska iD, Petr Slavik iD, Kryštof Šigut, Anthony R Fehr und 4 weitere

RSC Chemical Biology · 2026 · 7 (8) · 1559-1567

DOI: 10.1039/d6cb00139d ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Chemical Biology, 2026. Verfasst von Banhi Biswas und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University Baltimore Maryland USA anthony.leung@jh…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIGMS NIH HHS, Novo Nordisk Fonden, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GS-441524, the parent nucleoside of remdesivir, engages the SARS-CoV-2 macrodomain (Mac1) in cells, and its diphosphate metabolite exhibits enhanced inhibitory activity.

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University Baltimore Maryland USA anthony.leung@jhu.edu bbiswas1@jh.edu.
  • Center for Global Health and Diseases, Case Western Reserve University Cleveland Ohio USA.
  • InterRayBio, LLC Cleveland Ohio USA.
  • High Throughput Screening Laboratory, Del M. Shankel Structural Biology Center Kansas Lawrence USA.
  • SigutLabs Praha Czech Republic.
  • Department of Molecular Biosciences, University of Kansas Lawrence USA.

ORCID-Profile: Junlin Zhuo, Jürgen Bosch, Alessandro Panattoni, Michal Maryska, Petr Slavik, Takashi Tsukamoto, Anthony K L Leung

Förderung

  • NIGMS NIH HHS
  • Novo Nordisk Fonden
  • National Institutes of Health

Zitieren

APA

Biswas, B., Zhuo, J., Bosch, J., Vu, H., Pak, L., Raja, R., Roy, A., Panattoni, A., Maryska, M., Slavik, P., Šigut, K., Fehr, A. R., Abraham, R., Slusher, B. S., Tsukamoto, T., & Leung, A. K. L. (2026). Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metabolite. RSC Chemical Biology, 7(8), 1559-1567. https://doi.org/10.1039/d6cb00139d

Vancouver

Biswas B, Zhuo J, Bosch J, Vu H, Pak L, Raja R, et al. Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metabolite. RSC Chemical Biology. 2026;7(8):1559-1567. doi:10.1039/d6cb00139d

BibTeX
@article{Biswas2026,
  author = {Biswas, Banhi and Zhuo, Junlin and Bosch, Jürgen and Vu, Hien and Pak, Lorencia and Raja, Rameez and Roy, Anuradha and Panattoni, Alessandro and Maryska, Michal and Slavik, Petr and Šigut, Kryštof and Fehr, Anthony R and Abraham, Rachy and Slusher, Barbara S and Tsukamoto, Takashi and Leung, Anthony K L},
  title = {Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metabolite},
  journal = {RSC Chemical Biology},
  year = {2026},
  volume = {7},
  number = {8},
  pages = {1559--1567},
  doi = {10.1039/d6cb00139d}
}
Kostenlos starten →